Egyptian Hypertrophic Cardiomyopathy Program

Recruiting now

Conditions studied: Hypertrophic Cardiomyopathy

In brief

Egyptian HCM program aims at defining incidence, severity, phenotype, genotype and determinants of the disease in Egypt, and providing state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific.

Key facts

Study ID

NCT05884892

Run by

Magdi Yacoub Heart Foundation

People needed

2000

Starts

2014-01-01

Expected to finish

2030-01-01

Last updated by the study team

2023-06-01

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• All patients diagnosed with hypertrophic cardiomyopathy (index patients) who are willing and consented to participate in the registry.
• All family members of index patients who are willing and consented to participate in the registry.

You may not qualify if…

• Refusal to consent to participate in the registry program.

Where it is running

• Aswan Heart Centre - Magdi Yacoub Heart Foundation — Aswān, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.